VEGFA and cervical carcinoma: In this present study, the VEGF-A targeting ability of the new immuno-PET probe was assessed by using the VEGF-A expressing KB-3-1 (human cervix carcinoma) tumor-bearing CB17 SCID mouse model and in vivo PET/MRI imaging.